NCT05874362

Brief Summary

A violent death is defined by its brutality, unexpectedness and is secondary to an external cause (suicide, homicide, accident). Bereavement following a violent death constitutes a particular clinical situation, at risk of complications. Research on bereavement after a violent death shows higher risks of psychiatric and somatic complications than in bereavement by non-violent death. These complications, sometimes comorbid, take the form of depressive episodes, post-traumatic stress disorders, suicidal behavior and prolonged grief disorders after 12 months, precociously mediated by ruminations. Processes responsible for this increased risk of complications are poorly documented. Current literature relates mainly to socio-demographic and epidemiological factors which, alone, do not explain this difference in risks. Further research is needed exploring other kinds of data and processes. To our knowledge, there is no description of early neurocognitive functioning in people bereaved after violent death. This study aims at exploring early neurocognitive processes which can lead to complications in people bereaved by violent death.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2023Dec 2026

First Submitted

Initial submission to the registry

May 12, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 24, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

September 19, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

March 6, 2025

Status Verified

March 1, 2025

Enrollment Period

2.4 years

First QC Date

May 12, 2023

Last Update Submit

March 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Amplitude of the Late Positive Potential (LPP) component in unpredictable event condition

    Measure in Electroencephalography (EEG) of the Late Positive Potential (LPP), an Event Related Potential (ERP) relating to attention biases

    Between Day15 and Day30 after the death of one's loved one

Secondary Outcomes (3)

  • Amplitude of the Contingent Negative Variation (CNV ) component in unpredictable event condition

    Between Day15 and Day30 after the death of one's loved one

  • Amplitude of the alpha and beta power in unpredictable event condition

    Between Day15 and Day30 after the death of one's loved one

  • Comparison of Constant Errors (CE) relative to time estimates in the unpredictability condition (D15-J30) in people developing a psychiatric complication at 3 months and in people not developing these complications.

    Between Day15 and Day30 after the death of one's loved one

Study Arms (2)

Group with complications at 3 month

OTHER

Group composed with participants who develop a psychiatric complication (depressive episode or post traumatic stress disorder) 3 month after the death of their loved one.

Other: Diagnosis of depressive episode or post traumatic stress disorder

Group without complication at 3 month

OTHER

Group composed with participants who do not develop a psychiatric complication (depressive episode or post traumatic stress disorder) 3 month after the death of their loved one.

Other: No diagnosis of depressive episode or post traumatic stress disorder

Interventions

Clinical diagnosis of depressive episode or post traumatic stress disorder, confirmed

Group with complications at 3 month

No elements in clinical assessment for the diagnosis of a depressive episode or post traumatic stress disorder

Group without complication at 3 month

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • An age between 18 and 65 years old
  • Recent bereavement by violent death of a relative in first and second degree

You may not qualify if:

  • Protected adults
  • Lack of mastering French language
  • History of neurodegenerative disorder
  • History of psychiatric disorder treated pharmacologically with modification of the basic treatment in the month preceding the death
  • The take of an benzodiazepine treatment in the 24th hours before the first visit (T0)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Vinatier

Bron, 69678, France

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Edouard LEAUNE

    Vinatier Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: Subjects will be separated into two groups at the end of the study to conduct analyses, depending on the development of a psychiatric complication or not.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2023

First Posted

May 24, 2023

Study Start

September 19, 2023

Primary Completion

February 28, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 6, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations